Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

126
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
126
Factorial Design02:01

Factorial Design

13.0K
Factorial Analysis is an experimental design that applies Analysis of Variance (ANOVA) statistical procedures to examine a change in a dependent variable due to more than one independent variable, also known as factors. Changes in worker productivity can be reasoned, for example, to be influenced by salary and other conditions, such as skill level. One way to test this hypothesis is by categorizing salary into three levels (low, moderate, and high) and skills sets into two levels (entry level...
13.0K
Hazard Ratio01:12

Hazard Ratio

122
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
122
Blinding01:11

Blinding

2.4K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.4K
Randomized Experiments01:13

Randomized Experiments

6.9K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
6.9K
Crossover Experiments01:16

Crossover Experiments

2.8K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
2.8K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Treatment Effect Reanalysis of the Randomized Individual Screening Trial of Innovative Glioblastoma Therapy in Newly Diagnosed Glioblastoma With External Control Data.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Risk-adapted therapy guided by human papillomavirus (HPV) circulating tumor DNA in HPV-positive oropharyngeal cancer (ReACT 1.0): an exploratory phase II trial.

Nature communications·2026
Same author

Myeloma Precursors Erode Durable Immunity: Results of the IMPACT study.

Research square·2026
Same author

Ciltacabtagene autoleucel in high-risk smoldering multiple myeloma: the CAR-PRISM phase 2 trial.

Nature medicine·2026
Same author

Daratumumab in high-risk MGUS and low-risk smoldering myeloma: results of the Phase II D-PRISM study.

Nature communications·2026
Same author

Harmonized Estimation of Subgroup-Specific Treatment Effects in Randomized Trials: The Use of External Control Data.

Journal of the Royal Statistical Society. Series B, Statistical methodology·2026

相关实验视频

Updated: Jul 4, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
00:04

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.7K

不确定性指导的因子临床试验

Gopal Kotecha1,2, Steffen Ventz3, Sandra Fortini4

  • 1Department of Biostatistics, Harvard School of Public Health, 677 Huntington Ave, Boston, MA, 02115, USA.

Biostatistics (Oxford, England)
|February 8, 2024
PubMed
概括

本研究介绍了因子临床试验的贝叶斯响应适应性设计. 这些适应性设计优化了基于累积数据的治疗分配,旨在比传统方法更有效地最大限度地实现试验目标.

关键词:
贝叶斯的设计是贝叶斯的设计.工厂设计的设计.获取信息获取信息多臂临床试验的临床试验.最优的设计最优的设计.响应适应随机化随机化

更多相关视频

Experimental Research Examining How People Can Cope with Uncertainty Through Soft Haptic Sensations
09:07

Experimental Research Examining How People Can Cope with Uncertainty Through Soft Haptic Sensations

Published on: September 16, 2015

9.0K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.5K

相关实验视频

Last Updated: Jul 4, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
00:04

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.7K
Experimental Research Examining How People Can Cope with Uncertainty Through Soft Haptic Sensations
09:07

Experimental Research Examining How People Can Cope with Uncertainty Through Soft Haptic Sensations

Published on: September 16, 2015

9.0K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.5K

科学领域:

  • 临床试验 临床试验
  • 生物统计学 生物统计学
  • 贝叶斯的方法论 贝叶斯的方法论

背景情况:

  • 临床试验对于评估新型治疗组合和确定最佳策略至关重要.
  • 传统的因数设计经常使用平衡的随机化,这可能不适合所有试验目标.
  • 需要适应性设计,可以根据新出现的数据有效地将患者分配到治疗组合中.

研究的目的:

  • 引入一类贝叶斯响应适应设计,用于具有二进制结果的因数临床试验.
  • 开发一种算法,根据代表试验目标的指定实用函数来调整随机化概率.
  • 将这些新型自适应设计的性能与传统设计进行比较.

主要方法:

  • 开发了贝叶斯决策理论论据,为因数试验创建响应适应性随机化.
  • 嵌入了调查员定义的实用函数来指导自适应算法.
  • 进行了比较模拟研究,使用了手术前护理,戒烟和传染病预防试验中的现实场景.

主要成果:

  • 拟议的贝叶斯响应适应性设计在模拟研究中展示了比传统设计的潜在优势.
  • 不同的实用功能导致了具有独特操作特征的量身定制的因数设计.
  • 研究了适应性设计的非对称行为,提供了理论见解.

结论:

  • 贝叶斯响应适应性设计为因子临床试验提供了一种灵活且潜在更有效的方法.
  • 这些适应性策略可以根据特定的试验目标进行定制,例如估计干预效应或找到协同作用的组合.
  • 这些发现表明,自适应性随机化可以提高各种医学领域因数试验设计的效率和有效性.